Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2325 |
Neratinib
HKI-272,来那替尼 |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Neratinib (HKI-272) 是一种酪氨酸激酶受体抑制剂,可以抑制 HER2 和 EGFR (IC50=59/92 nM),具有不可逆性和口服活性。Neratinib 具有抗肿瘤活性,可以用于治疗乳腺癌。 | |||
T67385 |
Neratinib maleate
HKI-272 maleate |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Neratinib maleate (HKI-272 maleate) 是一种不可逆且具有口服活性和高选择性的 HER2 和 EGFR 抑制剂,IC50 值分别为 59 nM 和 92 nM。Neratinib maleate具有抗肿瘤活性,可用于治疗消化系统疾病、呼吸系统疾病、泌尿生殖系统疾病和皮肤和肌肉骨骼疾病,可用于研究乳腺癌和前列腺癌。 | |||
T71387 |
Neratinib maleate monohydrate
|
Others | Others |
Neratinib maleate monohydrate is an irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity. | |||
T70829 |
Neratinib pyridine N-oxide
|
Others | Others |
Neratinib pyridine N-oxide is an irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity. | |||
T70830 |
Neratinib dimethylamine N-oxide
|
Others | Others |
Neratinib dimethylamine N-oxide is an irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity. | |||
T70828 |
HBY-793
|
Others | Others |
HBY-793 is an HIV-1 proteinase inhibitor. | |||
T70827 |
MDL-102234
|
Others | Others |
MDL-102234 is an adenosine A1 receptor antagonist. |